Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Top 13 High Dividend Stocks to Buy According to Hedge Funds

In this article, we discuss top 13 high-dividend stocks to buy according to hedge funds. You can skip our detailed analysis of dividend stocks and their returns, and go directly to read Top 5 High Dividend Stocks to Buy According to Hedge Funds

Dividend stocks are gaining popularity among investors as these stocks can potentially increase their portfolios’ returns. Due to the pandemic in 2020, many companies in the US cut their dividends due to weak earnings. Even so, dividend payments significantly accounted for overall returns. According to a report by S&P Global, citing Bloomberg, the S&P 500 companies that raised their dividends delivered a 12.7% return in 2020, compared with a 6.5% decline in the dividend cutters.

The additional income earned through these dividends investments is beneficial for investors, especially in times of financial instability. This year, elite hedge funds are also growing bullish on high-dividend stocks as the market longs for yields due to growing inflation. Companies like The Coca-Cola Company (NYSE:KO), Johnson & Johnson (NYSE:JNJ), and The Procter & Gamble Company (NYSE:PG) are mainly popular among investors as these companies have maintained decades-long dividend growth streaks, providing regular income to shareholders.

Over the years, companies with strong dividend growth track records have performed well, outplaying their peers. Charles Schwab compiled Ned Davis Research’s data in its report on dividend investments. The report mentioned that companies that grew and initiated their dividends returned 13.74% from 1981 to 2020 versus a 10.3% return for the stocks that cut their dividends. The report also mentioned that reinvested dividends significantly increased overall S&P 500 returns from 1990 to 2020.

In the third quarter of 2022, dividend payments increased by $17.7 billion, compared with $17.6 billion in the previous quarter. Moreover, for the 12 months ending September 2022, US common dividend increases were $86.7 billion, up 20.7% from the same period last year, as reported by S&P Dow Jones Indices. In view of this, we will discuss high-dividend stocks to buy according to hedge funds.

Photo by Karolina Grabowska from Pexels

Our Methodology:

For this list, we used the data of 895 elite funds in Insider Monkey’s database as of the end of the second quarter of 2022 to select the most popular high-dividend stocks among these hedge funds. The stocks mentioned below have yields above 3%, as of October 6. They are ranked according to hedge fund positions.

Top 13 High Dividend Stocks to Buy According to Hedge Funds

13. Cisco Systems, Inc. (NASDAQ:CSCO)

Number of Hedge Fund Holders: 63


Dividend Yield as of October 6: 3.62%

Cisco Systems, Inc. (NASDAQ:CSCO) is a California-based technology company that provides hardware, software, and tech services and products. In FY22, the company generated over $12.7 billion in free cash flow and paid nearly $4 billion to shareholders through dividends and share repurchases. For fiscal Q4 2022, the company’s operating cash flow came in at $3.6 billion, in line with the previous quarter.

Cisco Systems, Inc. (NASDAQ:CSCO) currently pays a quarterly dividend of $0.38 per share for a dividend yield of 3.62%, as of October 6. The company has been raising its dividends consistently for the past 11 years, which makes it one of the best dividend stocks according to hedge funds.

In August, KGI Securities upgraded Cisco Systems, Inc. (NASDAQ:CSCO) to Outperform with a $53 price target, appreciating the company’s overall performance this year.

As of the close of Q2 2022, 63 hedge funds tracked by Insider Monkey owned stakes in Cisco Systems, Inc. (NASDAQ:CSCO), compared with 66 in the previous quarter. The combined value of these stakes is roughly $2 billion. Among these hedge funds, Citadel Investment Group was the company’s leading stakeholder in Q2.

In addition to dividend stocks like The Coca-Cola Company (NYSE:KO), Johnson & Johnson (NYSE:JNJ), and The Procter & Gamble Company (NYSE:PG), Cisco Systems, Inc. (NASDAQ:CSCO) is one of the best dividend stocks to consider.

Carillon Tower Advisers mentioned Cisco Systems, Inc. (NASDAQ:CSCO) in its Q1 2022 investor letter. Here is what the firm has to say:

Cisco Systems (NASDAQ:CSCO) traded lower as investors weighed how supply chain concerns would impact sales growth. The company has been upgrading its switching and routing offerings, which should lead to strong demand as on-site locations upgrade infrastructure.”

12. Intel Corporation (NASDAQ:INTC)

Number of Hedge Fund Holders: 65


Dividend Yield as of October 6: 5.28%

Intel Corporation (NASDAQ:INTC) is an American multinational semiconductor company that also specializes in cloud computing and data centers. The company is one of the best dividend stocks to buy as it has been making uninterrupted dividend payments for the past 28 years. Moreover, it also holds a seven-year track record of consistent dividend growth. It currently pays a quarterly dividend of $0.365 per share and has a yield of 5.28%, as of October 6.

In September, Deutsche Bank maintained its Hold rating on Intel Corporation (NASDAQ:INTC) with a $35 price target, highlighting the company’s quarterly earnings.

At the end of June 2022, 65 hedge funds in Insider Monkey’s database reported owning stakes in Intel Corporation (NASDAQ:INTC), down from 76 a quarter earlier. These stakes hold a collective value of over $2.53 billion.

Baron Funds mentioned Intel Corporation (NASDAQ:INTC) in its Q2 2022 investor letter. Here is what the firm has to say:

“Then, there is the case of Intel Corporation (NASDAQ:INTC). A blue-chip tech champion with a market capitalization of over $500 billion in early 2000, the stock was trading at a P/E multiple of 42. It was a fast-growing company whose stock price and multiple declined more or less in line with its peers. However, unlike Google, Intel’s net income has grown from $7.3 billion in 1999 to $19.9 billion in 2021, a compounded annual growth rate of just 4.7%. Its growth from the dot com era has not proven to be durable, and Intel has yet to trade at the price it attained in 1999.”

11. Broadcom Inc. (NASDAQ:AVGO)

Number of Hedge Fund Holders: 66


Dividend Yield as of October 6: 3.38%

Broadcom Inc. (NASDAQ:AVGO) is a California-based manufacturer and global supplier of a wide range of semiconductor and infrastructure software products. In September, BMO Capital maintained an Outperform rating on the stock with a $650 price target. The firm appreciated the company’s strong quarterly earnings and highlighted its strong semiconductor business.

In fiscal Q3 2022, Broadcom Inc. (NASDAQ:AVGO) reported a strong cash position. Its operating cash flow came in at $4.4 billion, up from $3.5 billion during the same period last year. The company’s free cash flow also grew to $4.3 billion, from $3.4 billion in the prior-year quarter. During the quarter, it returned $3.2 billion to shareholders, $1.7 billion of which represented dividend payments.

On September 1, Broadcom Inc. (NASDAQ:AVGO) declared a quarterly dividend of $4.10 per share, in line with its previous dividend. The company has been raising its dividends for the past 11 years, which makes it one of the best dividend stocks. As of October 6, the stock’s dividend yield came in at 3.38%.

At the end of Q2 2022, 66 hedge funds in Insider Monkey’s database owned stakes in Broadcom Inc. (NASDAQ:AVGO), down from 71 in the previous quarter. These stakes hold a total value of over $4 billion. Ken Fisher and Ken Griffin were the company’s leading stakeholders in Q2.

ClearBridge Investments mentioned Broadcom Inc. (NASDAQ:AVGO) in its Q4 2021 investor letter. Here is what the firm had to say:

“However, ClearBridge portfolio companies are responding by supporting their workforces and showing resilience in adapting and thriving. Semiconductor companies ClearBridge owns and engages with have been successful in advancing vaccinations in their global supply chains. In Malaysia, for example, Broadcom has taken part in PIKAS, a public-private partnership vaccination program focusing on the workforce in critical manufacturing sectors. By the summer of 2021 Broadcom was able to get over 90% of workers in its Penang factory at least one dose of vaccine, and roughly 73% fully vaccinated. Companies in the program also pay the administration cost for vaccinations including cases where the employee is no longer employed by the company before full immunization of the employee.”

10. The Goldman Sachs Group, Inc. (NYSE:GS)

Number of Hedge Fund Holders: 69


Dividend Yield as of October 6: 3.24%

The Goldman Sachs Group, Inc. (NYSE:GS) is an American investment banking company. In Q2 2022, the company reported strong earnings, beating Street estimates. It posted a GAAP EPS of $7.73 and revenue of $11.86 billion, which surpassed consensus by $1.04 and $1.16 billion, respectively. At the end of the quarter, the company had $288 billion in cash and cash equivalents, up from $274 billion in the previous quarter. It returned $1.22 billion to shareholders during the quarter, $719 million of which accounted for dividend payments.

On July 18, The Goldman Sachs Group, Inc. (NYSE:GS) declared a 25% hike in its dividends, which takes its quarterly payout to $2.50 per share. This was the company’s 10th consecutive year of dividend growth. As of October 6, the stock’s dividend yield came in at 3.24%.

In July, BMO Capital reiterated its Outperform rating on The Goldman Sachs Group, Inc. (NYSE:GS) with a $461 price target, highlighting the company’s impressive revenue-driven beat and improving profitability.

At the end of Q2 2022, 69 hedge funds tracked by Insider Monkey owned stakes in The Goldman Sachs Group, Inc. (NYSE:GS), down from 71 in the previous quarter. These stakes have a collective value of over $4.6 billion. Eagle Capital Management was the company’s leading stakeholder in Q2.

GoodHaven Capital Management mentioned The Goldman Sachs Group, Inc. (NYSE:GS) in its Q2 2022 investor letter. Here is what the firm has to say:

“We also initiated a position in The Goldman Sachs Group, Inc. (NYSE:GS) at an inexpensive valuation and are attracted by the potential durability of the company’s ability to generate high returns on equity driven in part by the growth in their existing and new franchises.”

9. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 69


Dividend Yield as of October 6: 3.02%

Bristol-Myers Squibb Company (NYSE:BMY) is a multinational pharmaceutical company that develops innovative medical solutions for patients with serious illnesses. In July, JPMorgan appreciated the company’s expanding portfolio and its solid performance in the recent quarter. The firm raised its price target on the stock to $85 with an Overweight rating on the shares.

On September 14, Bristol-Myers Squibb Company (NYSE:BMY) declared a quarterly dividend of $0.54 per share for a dividend yield of 3.02%, as of October 6. The company has been raising its dividends consistently for the past 16 years, coming through as one of the best dividend stocks on our list.

With stakes worth over $2.1 billion, 69 hedge funds tracked by Insider Monkey owned positions in Bristol-Myers Squibb Company (NYSE:BMY) in Q2 2022. In the previous quarter, 70 hedge funds owned stakes in the pharmaceutical company, worth over $2.4 billion. Two Sigma Advisors was the company’s leading stakeholder in Q2.

Baron Funds mentioned Bristol-Myers Squibb Company (NYSE:BMY) in its Q2 2022 investor letter. Here is what the firm has to say:

“We established a position in Bristol-Myers Squibb Company, a global biopharmaceutical company focused on discovering, developing, and selling medicines for patients in the therapeutic areas of oncology, immunology, cardiovascular, and neurology. The stock trades at a low valuation relative to its current earnings because the company faces loss of exclusivity on several key drugs over the next eight years, including Revlimid, Eliquis, and Opdivo.

At the same time, Bristol-Myers has multiple new products in the early stages of launch (e.g., Opdualag, Camzyos, Breyanzi, and Reblozyl), a robust new product pipeline (e.g., Deucravacitinib, Milvexian, and CELMoD agents), and a strong balance sheet combined with strong free cash flow generation that the company can use for acquisitions. Management believes these growth drivers can more than offset the loss of exclusivity and drive revenue growth through the end of the decade. Given the company’s low valuation, if the company can execute, we think there is substantial upside in the stock.”

8. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 70


Dividend Yield as of October 6: 3.63%

An American multinational pharmaceutical industry company, Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks on our list due to its strong dividend history. The company was a part of 70 hedge fund portfolios in Q2 2022, down from 79 in the previous quarter. The stakes owned by these hedge funds hold a collective value of over $2.8 billion.

In September, Pfizer Inc. (NYSE:PFE) declared a quarterly dividend of $0.40 per share, in line with its previous dividend. The company has been raising its dividends consistently for the past 12 years and its free cash flow generation signals future growth as well. As of October 6, the stock has a yield of 3.63%.

In Q2 2022, Pfizer Inc. (NYSE:PFE) reported an operating cash flow of $8.1 billion, up from $6.5 billion in the previous quarter. Its free cash flow stood at $7.4 billion, compared with $5.9 billion a quarter earlier. The company paid $4.5 billion in dividends to shareholders, which shows that its FCF is stable for shareholder returns.

ClearBridge Investments mentioned Pfizer Inc. (NYSE:PFE) in its Q4 2021 investor letter. Here is what the firm had to say:

“While the level of general turnover abated as we progressed through 2021, it remained high in one area: post-COVID-19 recovery plays. The concept behind this investment thesis was, and still is, straightforward: with the advent of effective vaccines, the path from pandemic to endemic is just a matter of time. As this transition occurs, the estimated excess savings of over $2 trillion built up on U.S. consumer balance sheets will unlock dramatic pent-up demand for experiences, especially global travel. This investment case seemed especially compelling when the Pfizer vaccine positively surprised markets in November 2020. As a result, we made post-COVID-19 stocks (which were trading well below our estimate of recovery value) a sizable theme within the portfolio. We understood this to be a more aggressive tilt in positioning because it required a major improvement in demand to catalyze fundamentals and drive price toward higher business values. While we accepted that recovery would not be smooth and that it would take time to deploy vaccines both domestically and globally, we decided that recovery was the logical path of least resistance and we were being well compensated for these risks. (Click here for the full text)

7. ConocoPhillips (NYSE:COP)

Number of Hedge Fund Holders: 71


Dividend Yield as of October 6: 3.83%

ConocoPhillips (NYSE:COP) is a Texas-based natural gas liquids company that specializes in the exploration and production of hydrocarbons. In August, Barclays raised its price target on the stock to $153 with an ‘Overweight’ rating on the shares, highlighting the company’s maintenance of its free cash flow yields.

ConocoPhillips (NYSE:COP) has been paying continuous dividends to shareholders since 1993. It currently pays a quarterly dividend of $0.46 per share with a dividend yield of 3.83%, as of October 6.

At the end of Q2, 71 hedge funds tracked by Insider Monkey owned stakes in ConocoPhillips (NYSE:COP), up from 67 in the previous quarter. The collective value of those stakes was over $2.42 billion. With over 6.7 million shares, Fisher Asset Management owned the largest position in the energy company in Q2.

Diamond Hill Capital mentioned ConocoPhillips (NYSE:COP) in its Q1 2022 investor letter. Here is what the firm had to say:

“We redeployed capital into ConocoPhillips (NYSE:COP), which was trading at a discount to our estimate of intrinsic value and is well positioned over the long run due to its low-risk asset base.”

6. Exxon Mobil Corporation (NYSE:XOM)

Number of Hedge Fund Holders: 72


Dividend Yield as of October 6: 3.55%

Exxon Mobil Corporation (NYSE:XOM) is next on our list of the best dividend stocks according to hedge funds. The company is one of the most popular energy corporations in the US and was founded in 1999 with the merger of Exxon and Mobil. Morgan Stanley lifted its price target on the stock to $113 in September and maintained an Overweight rating on the shares, holding a positive stance for companies that support low-carbon growth.

Exxon Mobil Corporation (NYSE:XOM) pays a quarterly dividend of $0.88 per share for a yield of 3.61%, as recorded on September 12. The company has sustained its annual dividend growth for 39 years in a row.

Of the 895 hedge funds tracked by Insider Monkey, 72 funds had investments in Exxon Mobil Corporation (NYSE:XOM) in Q2 2022, compared with 83 in the previous quarter. The total value of these investments came in at over $7.4 billion.

Exxon Mobil Corporation (NYSE:XOM) is a valuable addition to dividend portfolios alongside The Coca-Cola Company (NYSE:KO), Johnson & Johnson (NYSE:JNJ), and The Procter & Gamble Company (NYSE:PG).

First Eagle Investments mentioned Exxon Mobil Corporation (NYSE:XOM) in its Q2 2022 investor letter. Here is what the firm has to say:

“Integrated oil and gas giant Exxon Mobil performed well in the second quarter as continued high prices for energy products supported the stock. As the largest refiner in the US, the company has benefitted from wide “crack spreads,” or the margin between the cost of crude oil and the petroleum products extracted from it. Exxon continues to invest in refining capacity in the US, which industrywide has been in steady decline since 2019. We are pleased that Exxon has been using its strong cash flows to reduce debt and to return cash to shareholders through dividends and stock repurchases.”

Click to continue reading and see Top 5 High Dividend Stocks to Buy According to Hedge Funds

Suggested articles:

Disclosure. None. Top 13 High Dividend Stocks to Buy According to Hedge Funds is originally published on Insider Monkey.

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 75%.

For a ridiculously low price of just $24, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

  • The Name of the Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
  • Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
  • Lifetime Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund ANYTIME, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

  1. Head over to our website and subscribe to our Premium Readership Newsletter for just $24.
  2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
  3. Sit back, relax, and know that you’re backed by our ironclad lifetime money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!